Newcelx Ltd share price logo

Newcelx Ltd Share Price

NASDAQ: NCEL

Small Cap

$2.45

as on

Newcelx Ltd Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.41
    $2.49
    downward going graph

    1.63%

    Downside

    1.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Newcelx Ltd share price movements today

Previous Close
$2.45
Open
$2.45
Volume
407.5K
Day's Low - High
$2.41 - $2.49

Newcelx Ltd Historical Returns

1 Month Return
-14.93 %
3 Month Return
-6.84 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Newcelx Ltd Stock Fundamentals & Key Indicators

Check Newcelx Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.8M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Newcelx Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Newcelx Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Newcelx Ltd image
Newcelx Ltd
NA$10.8MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Newcelx Ltd Stock’s Investor Sentiment and Interest

Search interest for Newcelx Ltd Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-58% versus previous 30 day period

Newcelx Ltd Quarterly Profit & Loss

All numbers in Millions USD

Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Newcelx Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
Gross Profit
0
0
0
0
Operating Income
-11
-15
-11
-4
EBITDA
-11
-15
-11
-3
Interest Expense
0
0
0
0
Depreciation
1
1
2
1
Income Before Tax
-11
-16
-12
-1
Income Tax Expense
0
0
0
0
Net Income
-3
-4
-3
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Newcelx Ltd Quarterly Cash Flow

All numbers in Millions USD

Jun 2021
Dec 2021
Sep 2022
Mar 2023
Jun 2023
Mar 2024
Sep 2024
Mar 2025
Sep 2025
Net Income
-4
-7
-8
-7
-7
0
-2
0
-2
Operating Cash Flow
-9
-5
-7
-6
-7
-2
-1
-2
-2
Investing Cash Flow
0
0
4
-7
-
-
-
0
-
Financing Cash Flow
16
3
3
13
-
1
1
3
3
Change in Cash
6
-1
-4
7
-7
0
0
1
1

Newcelx Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-5
-5
-2
-11
-16
-12
-1
Operating Cash Flow
-2
0
0
-14
-13
-9
-4
Investing Cash Flow
-
0
0
0
-3
-
0
Financing Cash Flow
0
0
0
20
17
1
5
Change in Cash
-2
0
0
5
3
-8
0

Insights on Newcelx Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NCEL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Newcelx Ltd has experienced a drawdown of -95.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 84.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, NCEL stock has moved down by -95.1%

About Newcelx Ltd

NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.
OrganisationNewcelx Ltd
HeadquartersThe Circle 6, Zurich, Switzerland, 8058
CEOMr. Ronen Twito CPA
E-voting on sharesClick here to vote

Key Management of Newcelx Ltd

Name

Title

Prof. Michel Revel M.D., Ph.D.

Co-Founder, Chief Scientist, Head of the Scientific Advisory Board & Director

Mr. Yossi Ben-Yossef

Honorary President & Strategic Consultant

Mr. Omri Hagai

Chief Financial Officer

Mr. Alexander C. Zwyer M.B.A.

Chief Business Officer & Executive Director

Dr. Eric Konofal M.D., Ph.D.

Head of Doxa Program

Prof. Ariel Revel M.D.

Director of Medical Affairs

Mr. Ronen Twito CPA

CEO & Executive Chairman

FAQs

What is Newcelx Ltd share price today?

Newcelx Ltd share price today is $2.45 as on at the close of the market. Newcelx Ltd share today touched a day high of $2.49 and a low of $2.41.

What is the 52 week high and 52 week low for Newcelx Ltd share?

Newcelx Ltd share touched a 52 week high of $ on and a 52 week low of $ on . Newcelx Ltd stock price today i.e. is closed at $2.45,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Newcelx Ltd's market capitalisation today?

Newcelx Ltd market capitalisation is $0.00T as on .

How to invest in Newcelx Ltd Stock (NCEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Newcelx Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Newcelx Ltd Shares that will get you 0.6122 shares as per Newcelx Ltd share price of $2.45 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Newcelx Ltd Stock (NCEL) from India?

Indian investors can start investing in Newcelx Ltd (NCEL) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Newcelx Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Newcelx Ltd share’s latest price of $2.45 as on March 25, 2026 at 1:29 am IST, you will get 4.0816 shares of Newcelx Ltd. Learn more about fractional shares .